The positive inotropic response of the heart to catecholamines has been postulated to result from an increase in the intracellular level of cyclic AMP (adenosine 3′,5′-monophosphate), produced by activation of myocardial adenylate cyclase. According to this hypothesis, inhibition of phosphodiesterase, the enzyme which hydrolyzes cyclic AMP to inactive 5′-AMP, should enhance the cardiac effects of catecholamines. We therefore examined the effects of theophylline, an inhibitor of cardiac phosphodiesterase, on the isometric contractile response of cat papillary muscles to varying concentrations of norepinephrine (10 −11 to 10 −5 m), cyclic AMP (10 −4 to 5 × 10 −3 m) and dibutyryl cyclic AMP (10 −5 to 5 × 10 −3 m). The latter agent is a more lipid soluble derivative of cyclic AMP which is thought to reproduce the intracellular effects of the parent compound. Cyclic AMP produced no changes in isometric contractile function either in the presence or absence of theophylline. However, at a theophylline concentration (2.5 × 10 −4 m) which caused little increase in baseline contractile function (average increment in active tension less than 10%), a marked potentiation of the positive inotropic effects of norepinephrine and dibutyryl cyclic AMP was observed. The concentration of norepinephrine producing half-maximal increases in active tension and rate of tension development decreased from 10 −7 to 10 −8 m while that of dibutyryl cyclic AMP decreased from 8 × 10 −4 to 4 × 10 −4 m. Theophylline did not alter the positive inotropic effects of increasing extracellular calcium concentration (2.5 to 10 m m), an intervention which is not thought to directly influence intracellular cyclic AMP levels. Although indirect, these findings provide further evidence that the positive inotropic effects of catecholamines are mediated via the adenylate cyclase cyclic AMP system.
Read full abstract